Intact nuclear 'ghosts' containing small amounts of DNA were obtained from rat liver. Incubation of radiolabelled dihydrotestosterone with isolated nuclear-envelope fraction from male rat liver resulted in specific binding of the dihydrotestosterone to the membranes. Optimal binding occurred at 200C after 20h incubation. Storage for 2 weeks at -800C resulted in little loss of specific binding. Scatchard analysis revealed a class of binding sites with a KD of 23.2nm. Pronase and heat treatment destroyed the binding site. Androgens and glucocorticoids competed for labelled dihydrotestosterone binding to the ghosts, whereas oestrogens did not compete. Castration 24h before preparation of ghosts did not alter the binding site, and a similar class of binding sites was identified on female rat liver nuclear envelopes.
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Most steroid hormones act by the same intracellular mechanism (Gorski & Gannon, 1976; Chan & O'Malley, 1976a,b) . After binding to a cytosolic receptor protein present only in target tissues, the steroid-receptor complex translocates to the nucleus, where its interaction at the genome results in altered cellular function. For continued hormone action, the steroid and the receptor are recycled into the cytoplasm, or degradation of the receptor occurs and more receptor is synthesized.
Clearly the steroid-receptor complex must interact with the nuclear envelope during translocation into the nucleus and possibly during its recycling into the cytoplasm. This interaction may be a point where control of steroid-hormone action is exerted. We wish to determine the molecular mechanisms by which steroids traverse the nuclear envelope, and have established that a nuclearenvelope fraction isolated after heparin treatment of purified nuclei from the rat ventral prostate contains a saturable high-affinity binding site which is specific for androgens and which is not present in nuclei prepared from 24h-castrated animals (Lefebvre & Novosad, 1980) . We report here the characteristics of a dihydrotestosterone-binding site on a male rat liver nuclear-envelope fraction prepared by the method of Harris & Milne (1974) .
Materials and methods

Animals
Adult male and female rats (250-350g) were purchased from Woodlyn Laboratories, Guelph, Ontario, Canada, and maintained on a diet of Wayne Lab Blox (Allied Mills, Chicago, IL, U.S.A.) and water ad libitum. The rats were killed by decapitation and the livers quickly removed, rinsed in IOmM-Tris/HCl, pH7.4, containing 2mM-MgCl2 and 0.25M-sucrose (homogenization buffer), stripped of connective tissue, placed on ice and weighed.
Castration of male rats, where indicated, was performed via the scrotal route under diethyl ether anaesthesia.
Preparation ofnuclear envelopes
Purified nuclear envelopes were obtained by slight modifications of the method of Harris & Milne (1974) . All procedures were performed at 40C, unless stated otherwise. Purified nuclei were obtained from the livers after homogenization in the homogenization buffer with a Polytron (Brinkmann Instruments, Rexdale, Ontario, Canada) and sedimentation of the 7000g nuclear pellet through 2.2 M-sucrose in IOmM-Tris/HCl, pH 7.4, containing 2mM-MgCl2, at 1000OOg for 1.5h in a Beckman L2-65B ultracentrifuge (SW27 rotor, rav 11.6 cm).
The nuclear pellets were then washed twice at 3000g for 5 min in the homogenization buffer. The nuclei obtained by this method were relatively free of cytoplasmic tags as monitored by phase-contrast microscopy, and the combined pellets of purified nuclei were taken as the starting material for the isolation of nuclear envelope.
The nuclei were suspended in 1 mM-NaHCO3, pH 7.2 (40ml/20g starting wt. of tissue), by syringing through a large-bore needle and allowed to equilibrate for 5min before centrifuging at 33 000g for 5 min in a Sorvall RC-2B centrifuge (SS-34 rotor, rav. 4.25 cm). Each pellet was again resuspended in a.
small volume of 1 mM-NaHCO3 by syringing before being adjusted to the former volume and re-centrifuged as above after a further equilibration period of 5 min. The gelatinous swollen pellet was dispersed by the addition of 1 mM-NaHCO3 containing deoxyribonuclease I (Sigma Chemical Co., St. Louis, MO, U.S.A.; type DN-100) to give 40ml of suspension/ 20g of starting material with an enzyme concentration of lO,ug/ml. The suspension was then incubated at room temperature (200C) for 20min. The nuclear envelopes were washed twice in the same volume of 1 mM-NaHCO3, pH 7.2, by centrifugation for 5 min. Each pellet was resuspended in 2 ml of 1 mM-NaHCO3 and centrifuged at 5OOg for 5 min. The supernatant was layered over a discontinuous sucrose gradient made up of lOml of 2.0M-sucrose, lOml of 1.8 M-sucrose, lOml of 1.5 M-sucrose and 6 ml of 0.25 M-sucrose (all solutions made up in 10mM-Tris/HCl, pH 7.4). The gradient was then centrifuged for 90min at lOOOOOg in a Beckman L2-65B ultracentrifuge (SW27 rotor, rav. 11.6). The major band of purified nuclear envelope was removed from the gradients with a Pasteur pipette and washed twice in lOmM-Tris/ HCl, pH 7.4, at 33 OOOg for 5 min.
Assay of dihydrotestosterone binding to purified nuclear envelopesfrom rat liver Nuclear envelopes purified from the rat liver (200-400,ug of protein/assay tube) were incubated for the times and at the temperatures specified in a final volume of 0.25ml of lOmM-Tris/HCl, pH7.4, containing radioactive dihydrotestosterone. To a duplicate tube, 100-fold excess of unlabelled dihydrotestosterone was also added to determine non-specific binding. The reaction was stopped by centrifugation in a Microfuge B (Beckman Instruments, Edmonton, Alberta, Canada) and the supernatant was removed with a Pasteur pipette. The top of the pellet was washed twice with 0.25 ml of lOmM-Tris/HCl, pH7.4. The pellet was extracted with 0.20ml of 100% ethanol. Bound steroids were extracted from the pellet by incubation in 0.20ml of 100% ethanol for 30min at room temperature (200C) and, after centrifugation for lmin in the Microfuge B, 0.15 ml of the supernatant was removed and placed in a scintillation vial. After the ethanol had evaporated, 5 ml of toluene containing 0.3% (w/v) 2,5-diphenyloxazole (Fisher Scientific Co., Fair Lawn, NJ, U.S.A.) and 0.01% 1,4-bis-(5-phenyloxazol-2-yl)benzene (Nuclear Chicago, Des Plaines, IL, U.S.A.) was added and the radioactivity was assayed in a liquid-scintillation spectrophotometer. Specific binding was defined as that binding obtained by subtracting the radioactivity in the tube containing 100-fold excess of unlabelled steroid (non-specific binding) from that tube containing only labelled steroid (total binding).
Biochemical analyses
Protein content of nuclear-envelope fractions was determined by the method of Lowry et al. (1951) , with bovine serum albumin as standard. DNA was measured by the method of Thomas & Farquhar (1978) , with calf thymus DNA as standard. Phospholipid content was measured after extraction of nuclear-envelope lipids by the method of Garbus et al. (1963) , and measurement of organic phosphate was by the method of Bartlett (1959) .
Androgens bound to the liver nuclear envelope after incubation of the nuclear envelope with the radioactive dihydrotestosterone were analysed as follows. The washed pellet was resuspended in 1.0 ml of IO mM-Tris/HCl, pH 7.4 and transferred to a glass tube to which 5 ml of ethyl acetate was added. After vortex-mixing, the non-aqueous phase was removed. The aqueous phase was washed twice with ethyl acetate and the three extractions were combined. Anhydrous NaSO4 (1 g) was added to the extracts and this suspension was left overnight. The Na2SO4 was removed by filtration. The extracts were evaporated to dryness. Standards of dihydrotestosterone and testosterone were added in chloroform. T.l.c. was performed on 0.4 mm-thick silica-gelcoated plates and run twice in cyclohexane/ethyl acetate/acetic acid (36:24:0.07, by vol.). Dihydrotestosterone was detected by exposure to iodine vapour; testosterone was detected under u.v. Portions of the gel (1 cm) were scraped and assayed for radioactivity. Chemicals 5a- [ 1, 2, 4, 5, 6, 7, 16, Ci/mmol) was purchased from New England Nuclear, Boston, MA, U.S.A. All other unlabelled steroids were from Steraloids, Wilton, NH, U.S.A. Pronase (Type V Protease) was obtained from Sigma.
Results
Characterization of the male rat liver nuclearenvelope preparation
The rat liver nuclear-envelope fraction used in the studies described was prepared as described by Harris & Milne (1974) , with only slight modifications, to accommodate large quantities of starting material. The major band of purified nuclear envelope usually formed at the 1.5 M-/1.8 M-sucrose interface after the discontinuous-sucrose-gradient ultracentrifugation, but occasionally was positioned at the 1.8 M-/2.0 M-sucrose interface. Phase-contrast examination of the final membrane material obtained after removal of the band from either interface revealed the presence of intact nuclear 'ghosts' as described by Harris (1978) Characterization of androgen binding to the rat liver nuclear-envelopefraction Conditions for optimal binding of dihydrotestosterone to the male rat liver nuclear-envelope fraction were determined. Fig. 1 shows that optimal binding was obtained after incubations of 15 nmdihydrotestosterone with the nuclear-envelope fractions (0.300mg of protein/assay tube) for 20h at 200C. Fig. 2 Storage of the membrane at -800C for 14 days resulted in a loss of 34% of the specific binding measured under optimal conditions, compared with the binding observed with the fresh preparation (Fig.  3) . The loss of binding occurred at a fairly steady rate until day 10 of storage. However, storage at -15 0C resulted in a 60% loss in 24 h (Fig. 3) . For this reason, membrane preparations were routinely stored in liquid N2.
A Scatchard analysis of the binding of dihydrotestosterone to the male rat liver nuclear-envelope fraction was carried out. Fig. 4(a) shows that there was considerable non-specific binding, but that the KD for specific binding could be calculated as 23.2nM with an apparent number of binding sites of 578 fmol/mg of protein. As yet, more than one class of binding sites cannot be ruled out, especially in view of the fact that there is considerable non-specific binding. In addition, the amount of endogenously bound androgens is unknown at present.
After proteolytic digestion (1 mg/ml; 370C, Time (h) Fig. 1 36.5% of the specific binding. This evidence is consistent with the conclusion that the specific dihydrotestosterone-binding sites associated with the rat liver nuclear-envelope fraction are protein in nature.
To investigate the physiological significance of these dihydrotestosterone-binding sites, Scatchard analyses (not shown) of dihydrotestosterone binding to liver nuclear-envelope fractions obtained from male rats castrated 24h previously and from female rats were compared with Scatchard analyses of liver nuclear-envelope fractions obtained from intact male rats. Table 1 shows that the KD values for the binding of dihydrotestosterone to all three preparations are similar. The number of binding sites in the male rat preparations is similar, whereas the female rat liver nuclear-envelope preparations may have slightly fewer sites.
Steroid specificity of the dihydrotestosterone binding to the male rat liver nuclear-envelope preparation was examined by competition experi- PHidihydrotestosterone (0.9-65.OnM) with (0, to measure non-specific binding) and without (-, to measure total binding) unlabelled dihydrotestosterone (DHT; 100-fold excess). Specific binding was calculated from the difference in retained radioactivity in the presence and absence of unlabelled steroid (Fig. 4a) and plotted according to Scatchard (Fig. 4b) . The line of best fit was determined by linear regression analysis and the correlation coefficient was -0.94 (P < 0.01). ments in which 1-fold, 10-fold or 100-fold unlabelled competitor steroid was added to nuclear-envelope incubations with radiolabelled dihydrotestosterone (Fig. 5) . Testosterone, also an androgen, was not as effective a competitor for 15nM-[3Hldihydrotesto-sterone at 1500 nm as dihydrotestosterone. The oestrogens oestradiol and diethylstilboestrol competed less effectively for this site than did the androgens. However, the glucocorticoids dexamethasone and deoxycorticosterone competed as well as the androgens for the binding of labelled dihydrotestosterone.
Analysis of bound steroid revealed that after incubation of the membrane fraction with 15 nM radiolabelled dihydrotestosterone, 75% of the recovered label remained unchanged, whereas 5% was recovered as testosterone. In the presence of 100-fold unlabelled dihydrotestosterone, 55% of the radioactivity remained as dihydrotestosterone, whereas 23% was recovered as testosterone.
Discussion
An understanding of steroid-hormone action necessitates consideration of the process by which the steroid-receptor complex crosses the nuclear envelope before it interacts with the genome and possibly afterward as it is recycled into the cytoplasm during continued action of the hormone. The translocation of some proteins across the nuclear envelope appears to occur via the nuclear pores (Gurdon, 1970; Paine & Feldherr, 1972) , but there is a size limitation (Gurdon, 1970) . Whether translocation of the steroid-receptor complex occurs via the pores or not, the transport of such a complex across the nuclear membranes probably requires a specific series of interactions with components of the nuclear envelope. We have begun investigations on this aspect of steroid-hormone action in the androgen target tissue, the rat ventral prostate, by characterizing interactions of androgens with a nuclear-envelope fraction obtained from the rat ventral prostate by heparin treatment of purified nuclei (Lefebvre & Novosad, 1980) . However, this nuclear-envelope fraction did not contain nuclear pores. We wished to investigate interactions of steroids with a more intact preparation of the nuclear envelope and decided to use the nuclear 'ghost' preparation of Harris & Milne (1974) . While modifying this procedure to obtain ghosts from the rat ventral prostate, we investigated interactions of androgens with nuclear ghosts prepared from the male rat liver. Although the rat liver is not generally considered a primary target for sex hormones, sex steroids can affect certain hepatic functions in a manner consistent with the accepted model for the action of steroid hormones on their target tissues (Kurtz et al., 1976) , and androgen and oestrogen receptors in rat liver cytosol have been reported (Milin & Roy, 1973; Van Beurden-Lamers et al., 1974) .
The preparation of rat liver nuclear envelopes used in this study (Harris & Milne, 1974) results in a preparation of relatively intact nuclear ghosts which retain the nuclear inner membrane and nuclear outer membrane with morphologically well-preserved nuclear-pore complexes (Harris, 1978) . In our hands intact ghosts as monitored by phase-contrast microscopy were obtained, and the DNA content of the preparation compared with that reported by Harris (Milne et al., 1978) . The phospholipid content, on the other hand, is somewhat higher (0.32 versus 0.20mg/mg of protein). The RNA content of our preparation was not determined, but has been found to be approx. 0.09mg/mg of protein (Milne et al., 1978) . The density of the rat liver nuclear-envelope preparation was variable. Agutter & Gleed (1980) have reported that the density of sheep liver nuclear-envelope preparations varied according to the concentrations of nuclei during the lysis stage.
The experiments described in the present paper identify specific steroid-binding sites associated with the nuclear envelope. The measurement of steroidbinding sites involved incubation in vitro of the isolated nuclear-envelope fraction with labelled steroid. These studies therefore do not distinguish between binding of the labelled steroid to membrane sites previously occupied by endogenous unlabelled steroid and binding to unoccupied sites, nor do they distinguish between binding of steroid to a receptor of cytoplasmic origin which is in turn bound to a membrane site and to a site which does not involve receptors.
Scatchard analysis of the binding of dihydrotestosterone to the intact male rat liver indicated a class of binding sites having a relatively high affinity (KD 23.2nM) , although this is a lower affinity than that calculated for the class of binding sites investigated on the rat ventral-prostate nuclearenvelope fraction (KD 8.4nM ). The binding sites also differed in that they were not altered appreciably by castration. Indeed, sites with a similar KD and number were identified in female rat liver.
Competition experiments revealed that the other biologically active androgen, testosterone, competed somewhat less effectively than dihydrotestosterone for this site. Furthermore, steroid analysis showed that in the presence of 100-fold excess of unlabelled dihydrotestosterone more of the steroid is converted into testosterone. This conversion involves the 5a-reductase, which has been reported on the nuclear envelope (Moore & Wilson, 1972) , which would be active at the higher concentration of steroid. As testosterone binds as avidly to the site, this conversion would probably not significantly alter the amount of binding. Oestrogens did not compete well, but glucocorticoids competed as well as dihydrotestosterone. It would be of interest now to characterize further glucocorticoid binding to this preparation, as liver is recognized as a primary target tissue for glucocorticoids.
In summary, a binding site for androgens displaying high affinity and saturability has been identified on the liver nuclear envelope. Oestrogens do not compete for binding of androgens to this site, whereas glucocorticoids are effective competitors. As this class of binding sites is present in 24 hcastrated male rats, intact male rats and females, the physiological role of the sites is not clear, but may be involved in translocation of androgens and/or glucocorticoids into or out of the nucleus.
